Stroke, Vol 19, 349-351, Copyright © 1988 by American Heart Association
B Katz, M Sofonio, PD Lyden and MD Mitchell
Clinical studies have demonstrated elevated levels of both arachidonic acid
and prostaglandins in the cerebrospinal fluid of humans after ischemic
stroke and subarachnoid hemorrhage. Such increases in free fatty acid,
arachidonic acid, and prostaglandin concentrations suggest excessive
production and accumulation of these substances in the ischemic brain. We
used a rabbit model of ischemic infarction to examine the relation between
controlled central nervous system ischemia and cerebrospinal fluid
prostaglandin levels. We found that following stroke PGF2 alpha and not
PGD2 was the predominant prostaglandin present in the cerebrospinal fluid.
PGF2 alpha also underwent the largest percent increase over control
prostaglandin concentrations. This is similar to human and dog
cerebrospinal fluid studies, which demonstrate PGF2 alpha as the
predominant prostaglandin following ischemic injury. The lack of PGD2
elevation under ischemic conditions may suggest that the rabbit model is
more like stroke in humans than the rat or gerbil models. Our preliminary
work demonstrates that it is practical to study postischemic prostaglandin
changes in cerebrospinal fluid rather than in brain tissue in a rabbit
model of central nervous system ischemia.
ARTICLES
Prostaglandin concentrations in cerebrospinal fluid of rabbits under normal and ischemic conditions
Department of Ophthalmology, University of California, San Diego, La Jolla 92093.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |